Xu Bing, Liang Jian, Zou Hecun, Wang Jingwen, Xiong Yubo, Pei Jiao
Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, 441021, People's Republic of China.
Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Cancer Manag Res. 2022 Aug 31;14:2609-2623. doi: 10.2147/CMAR.S367020. eCollection 2022.
tsRNA is a type of small non-coding RNA derived from tRNA. Diffuse gliomas are the most common brain tumors. This investigation focused on tsRNA identification and characterization within gliomas.
The sequences of human tRNA and tsRNAs were taken from GtRNAdb, tRFdb and tRFexplorer databases. Data processing and bioinformatic analysis were performed with R or Python software. The expression of tsRNAs in glioma tissues was analyzed by qRT-PCR assay.
With computational approaches, we identified hundreds of tsRNAs with available expression abundance in the glioma datasets, most of them derived from the 3' end or 5' end of mature tRNA. Among the tsRNAs derived from tRNA-Leu-CAA, ts-26, tRFdb-3012a, and tRFdb-3012b (tRFdb-3012a/b) were significantly decreased in diffuse gliomas. The clinical survivals of glioma patients with low tsRNA (ts-26, tRFdb-3012a, and tRFdb-3012b) expression were remarkably worse than that of those with high expression. Expression of tRFdb-3012a/b was correlated with mutant status and promoter mutation in gliomas, and tRFdb-3012a/b and ts-23 tended to be highly expressed in patients with the mutant. The enrichment analysis showed that some tRFdb-3012a/b-related genes were enriched in RNA splicing and processing, the spliceosome pathway and astrocyte molecular signatures. Moreover, the 3' untranslated region of the gene was predicted to contain putative binding sites of tRFdb-3012a/b, ts-26 may directly bind to the 3' untranslated region of the gene, and the expressions of both RBM43 and HOXA13 were up-regulated in diffuse gliomas. High RBM43 and HOXA13 expressions were significantly associated with poor survival outcome of glioma patients.
These results suggest that tRNA-Leu-CAA-derived tsRNAs (ts-26, tRFdb-3012a, and tRFdb-3012b) could be explored as diagnostic and prognostic biomarkers for diffuse gliomas, and tRFdb-3012a/b and ts-26 may play an important role in the progression of gliomas, through binding and , respectively.
tsRNA是一种源自tRNA的小非编码RNA。弥漫性胶质瘤是最常见的脑肿瘤。本研究聚焦于胶质瘤中tsRNA的鉴定与特征分析。
人类tRNA和tsRNA的序列取自GtRNAdb、tRFdb和tRFexplorer数据库。使用R或Python软件进行数据处理和生物信息学分析。通过qRT-PCR检测分析tsRNA在胶质瘤组织中的表达。
通过计算方法,我们在胶质瘤数据集中鉴定出数百种具有可用表达丰度的tsRNA,其中大多数源自成熟tRNA的3'端或5'端。在源自tRNA-Leu-CAA的tsRNA中,ts-26、tRFdb-3012a和tRFdb-3012b(tRFdb-3012a/b)在弥漫性胶质瘤中显著降低。tsRNA(ts-26、tRFdb-3012a和tRFdb-3012b)低表达的胶质瘤患者的临床生存期明显比高表达患者差。tRFdb-3012a/b的表达与胶质瘤中的突变状态和启动子突变相关,并且tRFdb-3012a/b和ts-23在具有该突变的患者中倾向于高表达。富集分析表明,一些与tRFdb-3012a/b相关的基因在RNA剪接和加工、剪接体途径和星形胶质细胞分子特征中富集。此外,预测该基因的3'非翻译区包含tRFdb-3012a/b的假定结合位点,ts-26可能直接与该基因的3'非翻译区结合,并且RBM43和HOXA13在弥漫性胶质瘤中的表达均上调。高RBM43和HOXA13表达与胶质瘤患者的不良生存结果显著相关。
这些结果表明,源自tRNA-Leu-CAA的tsRNA(ts-26、tRFdb-3012a和tRFdb-3012b)可作为弥漫性胶质瘤的诊断和预后生物标志物进行探索,并且tRFdb-3012a/b和ts-26可能分别通过与和结合在胶质瘤进展中发挥重要作用。